Business Process Management

WHITE PAPERS AND CASE STUDIES

• De-Risking Biosimilar Development With A Clinically Validated And Commercially Proven Disposable Autoinjector

  Discover how a biopharmaceutical company can de-risk the launch process by choosing a suitable autoinjector technology and partner.

• When Every Sample Is A Life Trusted To Our Care: How CRL Automated Assay And Scale Throughput

  Discover how our technology played a critical role in CRL’s exceptionally fast development and scale-up of a saliva-based SARS-CoV-2 assay to meet the unprecedented testing need.

• Upstream Viral Safety: A Holistic Approach To Mitigating Contamination Risks

  The safety of biologics from adventitious agents requires a multilayered strategy of controlled manufacturing processes and risk mitigation to prevent contamination. 

• Automating Backup: Opportunities & Best Practices

  You already know that backing up your organization’s data isn’t a nice-to-have, it’s a need-to-have. The external threats alone warrant this. You could be one of the 50% of all organizations operating a data center that can’t withstand, or is unable to operate after, a natural disaster. Or, you could be one of the 39% of global organizations that experienced a ransomware attack in recent months.

• Mechanistic Chromatography Modeling: Opportunities And Challenges

  Catch up on the current opportunities and challenges for using mechanistic modeling to simulate and predict chromatographic behavior and experiments in silico. 

• Engaging Stakeholders With Visualization And Analytics

  The National Pollutant Discharge Elimination System (NPDES) permit program, created in 1972 by the Clean Water Act (CWA), helps address water pollution by regulating point sources that discharge pollutants into the waters of the United States.

• Optimizing Operations In Multiproduct Pharma Manufacturing Facilities

  When evaluating CDMO partners for your next manufacturing project, due diligence is in order. With short timelines, frequent changeovers between small batches, and a wide array of increasingly complex and highly potent therapies, modern, multiproduct facilities must be carefully designed and managed for efficient operations. What key features should you look for in prospective manufacturing partners’ facilities?

• Three Options To Viral Vector Manufacturing Capacity

  A recent Virtual Think Tank focused on the challenges and trends influencing design considerations for viral vector manufacturing facilities, and how they can impact companies developing cell and gene therapies.

• Biotech's Mirrored Universe: Predictive Engineering And Digital Twinning

  The biotechnology industry now can harness advanced engineering techniques that have helped save astronauts, save energy, and save countless millions of dollars.

• Multi-Axis Stages: Why Custom Aligned, Tuned, Error-Corrected XYZ Assemblies Are Better

  Multi-axis precision motion at the micron or sub-micron level is required in many industrial automation processes as well as in test and metrology applications. Users of such motion systems often ask: Should I just get the individual components and bolt them together myself, or rather specify a complete XYZ system, mounted, aligned, and tested by a specialist? The answer depends on expectations, performance requirements, and budget.

• Alternative Buffer Management Strategies To Achieve Downstream Process Improvements

  Understanding the alternative buffer management strategies available and the resources needed to execute them can help ensure you have the tools necessary to remain competitive in today’s growing bioprocessing industry.

• eRegulatory: A Site's Perspective

  Coastal Pediatric Research (CPR) was well aware of the eRegulatory trend that was surfacing. Before CPR selected a platform, the team gave some thought to what they wanted an eRegulatory system to contain and/or provide. Learn more about the criteria for their selection and what solution met their criteria.